13 results
PRE 14A
ANEB
Anebulo Pharmaceuticals Inc
19 Oct 23
Preliminary proxy
5:18pm
of the independent auditors; determines and approves the engagement of the independent auditors; determines whether to retain or terminate the existing … proposed permissible non-audit services; monitors the rotation of partners of the independent auditors on the Company’s audit engagement team
DEFR14A
ANEB
Anebulo Pharmaceuticals Inc
25 Oct 22
Revised proxy
5:27pm
of the independent auditors; determines and approves the engagement of the independent auditors; determines whether to retain or terminate the existing … permissible non-audit services; monitors the rotation of partners of the independent auditors on the Company’s audit engagement team as required
8-K
EX-3.1
ANEB
Anebulo Pharmaceuticals Inc
13 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render
8-K
EX-4.1
yuiy 0eux6
29 Sep 22
Anebulo Pharmaceuticals Announces $6.6 million Private Placement Financing
4:05pm
8-K
EX-10.1
1b1nhwzvrrh8
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
S-1/A
EX-3.4
11viv2blgu8fn yr83v
26 Apr 21
IPO registration (amended)
4:38pm
S-1/A
EX-1.1
a6w majup
26 Apr 21
IPO registration (amended)
4:38pm
S-1
EX-10.1
rmfkkp5xo8gmzpwo7qk
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.8
flyf 6mso4qh1xv
1 Apr 21
IPO registration
5:19pm
DRS/A
EX-10.1
sun9nofmmuykhk5jk
12 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next